Article
ALA-PDT, with 73-percent reduction, approved as AK treatment; effectiveagainst other skin tumors
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Nail Trends That Challenge Clinical Diagnosis
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Q&A: Peter Lio, MD, on Safety in Pediatric AD Management and the Promise of Precision Medicine
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Why Plant-Derived Exosomes are Revolutionizing Regenerative Skin Care, According to Frank Roesken, MD, PhD
Hydrafacial Launches HydraFillic 9-Peptide Booster for Advanced Skin Rejuvenation
Day 4 Recap: SDPA Annual Summer Dermatology Conference 2025
Top KOL Insights From SDPA Summer 2025
Dermatology Times' Weekly Crossword: SDPA Summer Edition
What’s Shaping the Future of Alopecia Treatment, According to Leading Clinicians